Arex Capital Loads Caly: A Bold Bet on CALY Stock
A fresh SEC filing shows AREX Capital Management opening a new stake in CALY with 453,000 shares worth about $5.29 mi...
Timing matters: automatic rebalancing should occur as your allocations drift beyond set thresholds.
18,157 articlesA fresh SEC filing shows AREX Capital Management opening a new stake in CALY with 453,000 shares worth about $5.29 mi...
A high-yield dividend stock jumped about 31% over three months. As March begins, investors must weigh income potentia...
GE Vernova sparked intraday excitement as investors reacted to new outlooks on its energy portfolio. This piece break...
When great growth ideas stumble, the long-term case often remains intact. This piece examines two names that have fal...
SPYI is delivering a near-12% yield year-to-date, but most distributions are classified as return of capital, which c...
A notable insider maneuver at CareDx drew attention to the stock. This article breaks down the sale, what it means fo...
AMD’s surprise move to buy MEXT promises AI-driven memory optimization that could trim data center costs. Learn what ...
Nike stock has fallen significantly from its 52-week peak, even as the CEO buys shares. This guide explains what the ...
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Two substantial share sales by Klaviyo's co-CEO in February and March sparked questions about whether this is a warni...
Biotech stocks can swing on earnings surprises. This article explains why lenz therapeutics stock crashed, what it me...
A big data-center lease helped Applied Digital stock soar, signaling strong demand for AI infrastructure. Learn what ...